Associations between flavan-3-ol intake and CVD risk in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk)

Free Radical Biology and Medicine

Volumn 84, Issue , 2015, Pages 1-10

  Vogiatzoglou, Anna ^a   Mulligan, Angela A ^b   Bhaniani, Amit ^b   Lentjes, Marleen A H ^b   McTaggart, Alison ^b   Luben, Robert N ^b   Heiss, Christian ^c   Kelm, Malte ^c   Merx, Marc W ^c   Spencer, Jeremy P E ^c   Schroeter, Hagen ^d   Khaw, Kay Tee ^b,e   Kuhnle, Gunter G C ^a,b  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d MARS INC   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cardio vascular diseases; EPIC Norfolk; Flavan 3 ols; Nutritional epidemiology

Indexed keywords

ASCORBIC ACID; CATECHIN; CHOLESTEROL; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVAN 3 OL; FLAVAN DERIVATIVE; GALLIC ACID; GALLOCATECHIN; MONOMER; PROANTHOCYANIDIN; THEAFLAVIN; THEAFLAVIN 3 GALLATE; THEAFLAVIN 3' GALLATE; THEAFLAVIN 3,3' DIGALLATE; THEARUBIGIN; UNCLASSIFIED DRUG; CARDIOVASCULAR AGENT; FLAVAN-3-OL; FLAVONOID;

ADULT; ARTICLE; BLOOD PRESSURE MONITOR; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHECKLIST; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; EUROPEAN; FEMALE; FOLLOW UP; FOOD COMPOSITION; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; AGED; CARDIOVASCULAR DISEASES; DIET; MIDDLE AGED; MORTALITY; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DIET; FEMALE; FLAVONOIDS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84928580489     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.03.005     Document Type: Article

References (54)

1. H. Schroeter, C. Heiss, J.P.E. Spencer, C.L. Keen, J.R. Lupton, and H.H. Schmitz Recommending flavanols and procyanidins for cardiovascular health: current knowledge and future needs Mol. Aspects Med. 31 6 2010 546 557 http://dx.doi. org/10.1016/j.mam.2010.09.008
2. de Sahagún B. Historia general de las cosas de Nueva España, 1590.
3. T.L. Dillinger, P. Barriga, S. Escarcega, M. Jimenez, D. Salazar Lowe, and L.E. Grivetti Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate J. Nutr. 130 8S Suppl 2000 2057S 2072S
4. C.L. Keen, R.R. Holt, P.I. Oteiza, C.G. Fraga, and H.H. Schmitz Cocoa antioxidants and cardiovascular health Am. J. Clin. Nutr. 81 1 Suppl 2005 298S 303S
5. C. Heiss, C.L. Keen, and M. Kelm Flavanols and cardiovascular disease prevention Eur. Heart J. 31 21 2010 2583 2592 http://dx.doi.org/10.1093/eurheartj/ehq332
6. C. Heiss, P. Kleinbongard, A. Dejam, S. Perré, H. Schroeter, H. Sies, and M. Kelm Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers J. Am. Coll. Cardiol. 46 7 2005 1276 1283 http://dx.doi.org/10.1016/j.jacc.2005.06.055
7. H. Schroeter, C. Heiss, J. Balzer, P. Kleinbongard, C. Keen, N. Hollenberg, H. Sies, C. Kwik-Uribe, H. Schmitz, and M. Kelm (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans Proc. Natl. Acad. Sci. USA 103 4 2006 1024 1029
8. W.M. Loke, J.M. Hodgson, J.M. Proudfoot, A.J. McKinley, I.B. Puddey, and K.D. Croft Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men Am. J. Clin. Nutr. 88 4 2008 1018 1025
9. L. Hooper, C. Kay, A. Abdelhamid, P.A. Kroon, J.S. Cohn, E.B. Rimm, and A. Cassidy Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials Am. J. Clin. Nutr. 95 3 2012 740 751 http://dx.doi.org/10.3945/ajcn.111.023457
10. K. Ried, T. Sullivan, P. Fakler, O.R. Frank, and N.P. Stocks Effect of cocoa on blood pressure Cochrane Database System. Rev 8 2012 1 83 http://dx.doi.org/10.1002/14651858.CD008893.pub2
11. S. Ellinger, A. Reusch, P. Stehle, and H.P. Helfrich Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach Am. J. Clin. Nutr. 95 6 2012 1365 1377 http://dx.doi.org/10.3945/ajcn.111.029330
12. H.H.H. Feringa, D.A. Laskey, J.E. Dickson, and C.I. Coleman The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials J. Am. Diet. Assoc. 111 8 2011 1173 1181 http://dx.doi.org/10.1016/j.jada.2011.05.015
13. N.K. Hollenberg, G. Martinez, M. McCullough, T. Meinking, D. Passan, M. Preston, A. Rivera, D. Taplin, and M. Vicaria-Clement Aging, acculturation, salt intake, and hypertension in the Kuna of Panama Hypertension 29 1 Pt 2 1997 171 176 http://dx.doi.org/10.1161/01.HYP.29.1.171
14. A. Cassidy, E.B. Rimm, E.J. O'Reilly, G. Logroscino, C. Kay, S.E. Chiuve, and K.M. Rexrode Dietary flavonoids and risk of stroke in women Stroke 43 4 2012 946 951 http://dx.doi.org/10.1161/STROKEAHA.111.637835
15. A. Cassidy, E.J. O'Reilly, C. Kay, L. Sampson, M. Franz, J. Forman, G. Curhan, and E.B. Rimm Habitual intake of flavonoid subclasses and incident hypertension in adults Am. J. Clin. Nutr. 93 2 2011 338 347 http://dx.doi.org/10.3945/ajcn.110.006783
16. C. Samieri, Q. Sun, M.K. Townsend, E.B. Rimm, and F. Grodstein Dietary flavonoid intake at midlife and healthy aging in women Am. J. Clin. Nutr. 100 6 2014 1489 1497 http://dx.doi.org/10.3945/ajcn.114.085605
17. P.J. Mink, C.G. Scrafford, L.M. Barraj, L. Harnack, C.-P. Hong, J.A. Nettleton, and D.R. Jacobs Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women Am. J. Clin. Nutr. 85 3 2007 895 909
18. M.L. McCullough, J.J. Peterson, R. Patel, P.F. Jacques, R. Shah, and J.T. Dwyer Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults Am. J. Clin. Nutr. 95 2 2012 454 464 http://dx.doi.org/10.3945/ajcn.111.016634
19. I.C. Arts, P.C. Hollman, E.J. Feskens, HB Bueno de Mesquita, and D. Kromhout Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study Am. J. Clin. Nutr. 74 2 2001 227 232
20. B. Buijsse, E.J.M. Feskens, F.J. Kok, and D. Kromhout Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study Arch. Intern. Med. 166 4 2006 411 417 http://dx.doi.org/10.1001/.411
21. B. Buijsse, C. Weikert, D. Drogan, M. Bergmann, and H. Boeing Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults Eur. Heart J. 31 13 2010 1616 1623 http://dx.doi.org/10.1093/eurheartj/ehq068
22. S.C. Larsson, J. Virtamo, and A. Wolk Chocolate consumption and risk of stroke: a prospective cohort of men and meta-analysis Neurology 79 12 2012 1223 1229 http://dx.doi.org/10.1212/WNL.0b013e31826aacfa
23. A. Vogiatzoglou, A.A. Mulligan, R.N. Luben, M.A.H. Lentjes, C. Heiss, M. Kelm, M. Merx, J.P.E. Spencer, H. Schroeter, and G.G.C. Kuhnle Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union Br. J. Nutr. 111 8 2014 1463 1473
24. Global status report on noncommunicable diseases 2010 2011 World Health Organization Geneva, Switzerland
25. V. Knaze, R. Zamora-Ros, L. Lujan-Barroso, I. Romieu, A. Scalbert, N. Slimani, E. Riboli, C.T. van Rossum, H.B. Bueno-de-Mesquita, and A. Trichopoulou Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study Br. J. Nutr. 108 6 2012 1095 1108 http://dx.doi.org/10.1017/S0007114511006386
26. N.E. Day, S. Oakes, R.N. Luben, K.-T. Khaw, S.A. Bingham, A.A. Welch, and N.J. Wareham EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer Br. J. Cancer 80 Suppl 1 1999 95 103
27. A.A. Welch, A. McTaggart, A.A. Mulligan, R.N. Luben, N. Walker, K.-T. Khaw, N.E. Day, and S.A. Bingham DINER (data into nutrients for epidemiological research) - a new data-entry program for nutritional analysis in the EPIC-Norfolk cohort and the 7-day diary method Public Health Nutr. 4 6 2001 1253 1265
28. Lentjes, M. A. H.; McTaggart, A.; Mulligan, A. A.; Powell, N. A.; Parry-Smith, D.; Luben, R. N.; Bhaniani, A.; Welch, A. A.; Khaw, K.-T. Dietary intake using 7-day diaries in British men and women in the EPIC-Norfolk Study: a focus on methodological issures. Br. J. Nutr. In press.
29. N.J. Wareham, R. Jakes, K. Rennie, J. Mitchell, S. Hennings, and N.E. Day Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire Int. J. Epidemiol. 31 1 2002 168 174
30. K.T. Khaw, S. Bingham, A. Welch, R. Luben, N. Wareham, S. Oakes, and N. Day Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study Lancet 357 9257 2001 657 663
31. S. Sinha, P.K. Myint, R.N. Luben, and K.T. Khaw Accuracy of death certification and hospital record linkage for identification of incident stroke BMC Med. Res. Methodol 8 2008 74 http://dx.doi.org/10.1186/1471-2288-8-74
32. USDA USDA Database for the flavonoid content of selected foods 2011 US Department of Agriculture Beltsville: MD
33. USDA USDA Database for the proanthocyanidin content of selected foods 2007 US Department of Agriculture Beltsville, MD
34. Neveu, V.; Perez-Jimenez, J.; Vos, F.; Crespy, V.; du Chaffaut, L.; Mennen, L.; Knox, C.; Eisner, R.; Cruz, J.; Wishart, D., et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford) 2010;2010:bap024. doi:10.1093/database/bap024.
35. A.A. Mulligan, G.G.C. Kuhnle, M.A. Lentjes, V. van Scheltinga, N.A. Powell, A. McTaggart, A. Bhaniani, and K.T. Khaw Intakes and sources of isoflavones, lignans, enterolignans, coumestrol and soya-containing foods in the Norfolk arm of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk), from 7 d food diaries, using a newly updated database Public Health Nutr. 16 8 2012 1454 1462 http://dx.doi.org/10.1017/S1368980012003904
36. R.B. D'Agostino Sr., R.S. Vasan, M.J. Pencina, P.A. Wolf, M. Cobain, J.M. Massaro, and W.B. Kannel General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 6 2008 743 753 http://dx.doi.org/10.1161/CIRCULATIONAHA.107.699579
37. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, J.P. Vandenbroucke, and S. Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 370 9596 2007 1453 1457 http://dx.doi.org/10.1016/S0140-6736(07)61602-X
38. I.C. Arts, D.R. Jacobs, L.J. Harnack, M. Gross, and A.R. Folsom Dietary catechins in relation to coronary heart disease death among postmenopausal women Epidemiology 12 6 2001 668 675
39. L. Hartley, N. Flowers, J. Holmes, A. Clarke, S. Stranges, L. Hooper, and K. Rees Green and black tea for the primary prevention of cardiovascular disease Cochrane Database System. Rev 6 2013 CD009934 http://dx.doi.org/10.1002/14651858.CD009934.pub2
40. H.H. Feringa, D.A. Laskey, J.E. Dickson, and C.I. Coleman The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials J. Am. Diet. Assoc. 111 8 2011 1173 1181 http://dx.doi.org/10.1016/j.jada.2011.05.015
41. F.J. He, and G.A. MacGregor Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health J. Hum. Hypertens. 16 11 2002 761 770 http://dx.doi.org/10.1038/sj.jhh.1001459
42. T.P. Erlinger, W.M. Vollmer, L.P. Svetkey, and L.J. Appel The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives Prev. Med. 37 4 2003 327 333
43. G.G.C. Kuhnle, C. Dell'Aquila, S.A. Runswick, and S.A. Bingham Variability of phytoestrogen content in foods from different sources Food Chem. 113 2009 1184 1187
44. J.I. Ottaviani, T.Y. Momma, C. Heiss, C. Kwik-Uribe, H. Schroeter, and C.L. Keen The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo Free Radic. Biol. Med. 50 2 2011 237 244 http://dx.doi.org/10.1016/j.freeradbiomed.2010.11.005
45. C. Andres-Lacueva, M. Monagas, N. Khan, M. Izquierdo-Pulido, M. Urpi-Sarda, J. Permanyer, and R.M. Lamuela-Raventos Flavanol and flavonol contents of cocoa powder products: influence of the manufacturing process J. Agric. Food Chem. 56 9 2008 3111 3117 http://dx.doi.org/10.1021/jf0728754
46. W.J. Hurst, S.H. Krake, S.C. Bergmeier, M.J. Payne, K.B. Miller, and D.A. Stuart Impact of fermentation, drying, roasting and Dutch processing on flavan-3-ol stereochemistry in cacao beans and cocoa ingredients. Chem Central J. 5 2011 53 http://dx.doi.org/10.1186/1752-153X-5-53
47. J.I. Ottaviani, C. Kwik-Uribe, C.L. Keen, and H. Schroeter Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans Am. J. Clin. Nutr. 95 4 2012 851 858 http://dx.doi.org/10.3945/ajcn.111.028340
48. EFSA Panel on Dietetic Products NaAN. Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA J. 2012;10(7):2809-30.
49. Y. Inaba, J.A. Chen, and S.R. Bergmann Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis Int. J. Cardiovasc. Imaging 26 6 2010 631 640 http://dx.doi.org/10.1007/s10554-010-9616-1
50. J.R. Lupton, S.A. Atkinson, N. Chang, C.G. Fraga, J. Levy, M. Messina, D.P. Richardson, B. van Ommen, Y. Yang, and J.C. Griffiths Exploring the benefits and challenges of establishing a DRI-like process for bioactives Eur. J. Nutr. 53 Suppl 1 2014 1 9 http://dx.doi.org/10.1007/s00394-014-0666-3
51. Institute of Medicine (US) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. In: Micheel C, Ball J, eds. Washington, DC; 2010.
52. J.I. Ottaviani, T.Y. Momma, G.K. Kuhnle, C.L. Keen, and H. Schroeter Structurally related (-)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards In press Free Radic. Biol. Med. 2012 http://dx.doi.org/10.1016/j.freeradbiomed.2011.12.010
53. X. Tzounis, J. Vulevic, G.G.C. Kuhnle, T. George, J. Leonczak, G.R. Gibson, C. Kwik-Uribe, and J.P.E. Spencer Flavanol monomer-induced changes to the human faecal microflora Br. J. Nutr. 99 4 2008 782 792 http://dx.doi.org/10.1017/S0007114507853384
54. M. Nichols, N. Townsend, R. Luengo-Fernandez, J. Leal, A. Gray, P. Scarborough, and M. Rayner European cardiovascular disease statistics 2012 2012 European Heart Network Brussels